COYA
Coya Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.53
-0.22 ▼ -4.63%
🌙 3월 13일 6:02 PM ET (한국 3/14 07:02)
$4.51
-0.02 ▼ -0.42%
| Index | - | P/E | - | EPS (ttm) | -1.1 | Insider Own | 5.69% | Shs Outstand | 0.02B | Perf Week | -5.43% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | -24.55% | Insider Trans | - | Shs Float | 0.02B | Perf Month | -8.11% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.27 | Inst Own | 38.12% | Short Float | 4.28% | Perf Quarter | -25.62% |
| Income | -0.02B | P/S | 23.76 | EPS this Y | -21.8% | Inst Trans | 17.13% | Short Ratio | 3.98 | Perf Half Y | -27.05% |
| Sales | 0.00B | P/B | 2.78 | EPS next 5Y | -5.98% | ROA | -54.54% | Short Interest | 0.84M | Perf YTD | -21.9% |
| Book/sh | 1.63 | P/C | 3.37 | EPS past 3/5Y | -24.55% -89.45% | ROE | -62.18% | 52W High | -41.55% ($7.75) | Perf Year | -30.09% |
| Cash/sh | 1.34 | P/FCF | - | Sales past 3/5Y | - | ROIC | -67.56% | 52W Low | 14.97% ($3.94) | Perf 3Y | -4.63% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -53.2% | Gross Margin | 99.31% | Volatility(W/M) | 5.08% 5.36% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 16.71 | Sales Y/Y TTM | -58.26% | Oper. Margin | -503.76% | ATR (14) | 0.28 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.73 | EPS Q/Q | 52.16% | Profit Margin | -462.25% | RSI (14) | 41.1 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.73 | Sales Q/Q | - | SMA20 | -5.87% ($4.81) | Beta | 0.28 | Target Price | $16.07 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -5.92% ($4.82) | Rel Volume | 0.65 | Prev Close | $4.75 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 44.23% -3.67% | SMA200 | -20.75% ($5.72) | Avg Volume(3M) | 0.21M | Price | $4.53 |
| IPO | 2022/12/29 | Option/Short | Yes/Yes | Trades | 1339 | Volume | 138,198 | Change | -4.63% |
뉴스 로딩 중...